index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Myopathy Antisynthetase syndrome Bioelectrical impedance analysis Inclusion body myositis B cell homeostasis Inborn errors of metabolism Adult Systems biology Anti-IgE IgG Animals Myocarditis Anticorps spécifique des myosites Antibodies Abnormal movement Biomarkers Dermatomyositis Skeletal muscle Interferon Anti-MDA5 autoantibodies Antibody responses Adolescence AAV vector Antiphospholipid syndrome Cardio-oncology Interstitial lung disease Adverse drug reactions Amyotrophic lateral sclerosis Autoantibody Female AAV humoral immunity IMNM Inflammatory myopathy Aldosterone Auto-immunité Cancer Deep immune profiling Amyotrophy Adeno-associated virus vector Outcome measures Agalsidase Auto‐antibodies Acid-alpha-glucosidase Autoimmune diseases Biomarker Anti-Mi2 AAV Aged Antisynthétase Pharmacology Immune checkpoint inhibitors Anti-agalsidase antibodies Arthritis Biomarqueurs Active Polymyositis Idiopathic inflammatory myopathies COVID-19 Gene therapy Acute Kidney Injury/epidemiology/etiology Multidisciplinarity Sphingosine-1-phosphate Myositis and muscle disease Immunotherapy Anémie hémolytique Auto-antibodies Anti-interleukin-6 Inflammation Anti-synthetase syndrome Myositis IBM Machine learning Anticorps anti-agalsidase Cytokines Autoantibodies Mass cytometry Biopsy Male Anti-drug antibodies Case reports Prognosis Adjudication Middle Aged Adeno-associated virus Fabry disease AAV vectors B-lymphocyte Aldostérone Lysosomal storage diseases Humans Assisted communication devices Antisynthetase Autoimmunity Adeno-associated vector Analyses multidimensionnelles DM AAV antibody Anti‐mitochondrial antibodies Dependovirus/genetics/immunology Muscle Data integration